CBT-I: Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition
Study Details
Study Description
Brief Summary
Background: Neuropsychiatric conditions, such as insomnia, anxiety, depression, and pain are the most common symptoms experienced by nurses after acute infection of COVID-19. Although medication can assist nurses to improve these symptoms simultaneously in a short period of time, they are at risk of overuse of benzodiazepine hypnotics. Previous research supports the usefulness of cognitive behavioral therapy for insomnia (CBT-I) as self-management strategies in adults with insomnia, anxiety, depression, and pain. However, their effects on post COVID-19 condition have not been researched, and no previous head-to-head study compared the effects on these two approaches on insomnia and neuropsychiatric symptoms.
Aim: To investigate the effects of CBT-I on insomnia, anxiety, depression, and pain in nurses with post COVID-19 condition.
Methods: In this two-arm, parallel randomized controlled trial, 100 participants will be 1:1 randomly assigned to one of two groups (CBT-I and control). The intervention phase will last 6 weeks, followed by a three-month follow-up. Primary outcomes are insomnia severity and sleep quality, whereas anxiety, depression, pain, and health-related quality of life are secondary outcomes. These variables will be assessed before and after the intervention, and at 1, 2, and 3 months after the end of the intervention. Additionally, discontinuing benzodiazepine hypnotics will be measured at 3 months after the end of the intervention.
Discussion: This study will provide evidence of the effects of CBT-I on improving insomnia, anxiety, depression, and pain among nurses with post COVID-19 condition. Results could also enhance means by which to discontinue benzodiazepine hypnotics.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: cognitive behavioral therapy 6 weeks cognitive-behavioral therapy for insomnia |
Behavioral: cognitive behavioral therapy
6 weeks cognitive behavioral therapy
|
| No Intervention: treat as usual provide usual care |
Outcome Measures
Primary Outcome Measures
- insomnia severity [20 weeks]
measured by Insomnia Severity Index before and after the intervention, and at 1, 2, and 3 months after the end of the intervention
- sleep quality [20 weeks]
measured by Pittsburgh Sleep Quality Index
- sleep efficiency [20 weeks]
measured by Fitbit Charge 5
Secondary Outcome Measures
- anxiety [20weeks]
measured by Generalized Anxiety Disorder 7-Item
- depression [20weeks]
measured by Patient Health Questionnaire 9 item
- health-related quality of life [20weeks]
measured by 36-Item Short Form Health Survey
Eligibility Criteria
Criteria
Inclusion Criteria:
- nurses with post COVID-19 condition
Exclusion Criteria:
- history of sleep apnea, narcolepsy, pregnant, seizure, with pacemaker
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Tri-Service General Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- A202205210